{
  "company": {
    "name": "ProteoFormiX",
    "website": "https://proteoformix.com/",
    "record": "https://startuphistory.org/c/proteoformix.com"
  },
  "status": null,
  "history_since": "2020-09-18T10:20:36.000Z",
  "baseline": {
    "snapshot_id": "3273e5ac931d51fdeee0f20eb759ac676b21d0cbdb66cd85dcbeda78fcb21e86",
    "observed_at": "2020-09-18T10:20:36.000Z",
    "headline": "We Speak Peptides | ProteoFormiX | Beerse",
    "description": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
    "evidence": "https://web.archive.org/web/20200918102036/https://www.proteoformix.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T20:10:51.772Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-06T20:10:51.772Z",
      "variants": [
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2020-09-18T10:20:36.000Z",
          "evidence": "https://web.archive.org/web/20200918102036/https://www.proteoformix.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2021-01-17T02:26:25.000Z",
          "evidence": "https://web.archive.org/web/20210117022625/https://www.proteoformix.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2021-07-29T08:09:25.000Z",
          "evidence": "https://web.archive.org/web/20210729080925/https://www.proteoformix.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2022-08-16T12:30:56.000Z",
          "evidence": "https://web.archive.org/web/20220816123056/https://www.proteoformix.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2023-03-31T08:50:33.000Z",
          "evidence": "https://web.archive.org/web/20230331085033/https://www.proteoformix.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2023-08-16T12:41:21.000Z",
          "evidence": "https://web.archive.org/web/20230816124121/https://www.proteoformix.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2024-02-29T01:11:51.000Z",
          "evidence": "https://web.archive.org/web/20240229011151/https://www.proteoformix.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2025-01-20T18:16:17.000Z",
          "evidence": "https://web.archive.org/web/20250120181617/https://www.proteoformix.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2025-07-20T02:45:50.000Z",
          "evidence": "https://web.archive.org/web/20250720024550/https://www.proteoformix.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2026-03-06T23:17:34.000Z",
          "evidence": "https://web.archive.org/web/20260306231734/https://www.proteoformix.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We Speak Peptides | ProteoFormiX | Beerse",
          "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
          "observed_at": "2026-11-06T20:10:51.772Z",
          "evidence": "https://www.proteoformix.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "We Speak Peptides | ProteoFormiX | Beerse",
      "subhead": "ProteoFormiX is running a top-down proteomics-based translational biomarker discovery platform. We employ state-of-the-art and proprietary technology to identify disease-associated proteoforms (e.g., ",
      "from": "2020-09-18T10:20:36.000Z",
      "to": "2026-11-06T20:10:51.772Z",
      "captures": 11,
      "evidence": "https://www.proteoformix.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2020-09-18T10:20:36.000Z",
          "to": "2026-11-06T20:10:51.772Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “ProteoFormiX” company record, https://startuphistory.org/c/proteoformix.com"
}